Quantcast
Last updated on April 24, 2014 at 12:48 EDT

Latest Asplenia Stories

2012-11-08 12:26:57

SWIFTWATER, Pa., Nov. 8, 2012 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the Pediatric Infectious Disease Journal (PIDJ) has published the pivotal clinical trial data used by the U.S. Food and Drug Administration (FDA) to support the license expansion for Sanofi Pasteur's meningococcal conjugate vaccine, Menactra(®) (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to...

2012-05-04 09:11:14

New discovery of a genetic mutation in congenital asplenia may lead to genetic prenatal screening in patients with the rare, but deadly, disorder Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. The gene, Nkx2.5, was shown to regulate genesis of the spleen during early...

2008-10-23 09:00:10

The U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously yesterday to recommend that adults ages 19 to 64 with asthma receive pneumococcal polysaccharide vaccine (PPSV23), known as PNEUMOVAX(R) 23 (Pneumococcal Vaccine Polyvalent). Merck & Co., Inc. is the sole supplier of PNEUMOVAX 23 in the United States. The ACIP based this recommendation on study data that showed an increased risk of pneumococcal disease among...